Classification of patients with breast cancer according to Nottingham Prognostic Index highlights significant differences in immunohistochemical marker expression

被引:0
作者
Fisnik Kurshumliu
Lumturije Gashi-Luci
Shahin Kadare
Mehdi Alimehmeti
Ugur Gozalan
机构
[1] University Clinical Center,Institute of Anatomic Pathology
[2] Medical School,Shërbimi i AnatomisëPatologjike
[3] University of Pristina,undefined
[4] Laboratori Diagnostik Morfopatologjik,undefined
[5] Qendra Spitalore Universitare NënaTerezë,undefined
[6] American Hospital Kosova,undefined
来源
World Journal of Surgical Oncology | / 12卷
关键词
Breast cancer; Nottingham Prognostic Index; Immunohistochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 258 条
[1]  
Rakha EA(2014)Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer Br J Cancer 110 1688-1697
[2]  
Soria D(2013)Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers Br J Cancer 109 1886-1894
[3]  
Green AR(2010)A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients Comput Biol Med 40 318-330
[4]  
Lemetre C(2010)Breast cancer prognostic classification in the molecular era: the role of histological grade Breast Cancer Res 12 207-8
[5]  
Powe DG(1999)Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group Breast Cancer Res Treat 53 1-752
[6]  
Nolan CC(2000)Molecular portraits of human breast tumours Nature 406 747-10874
[7]  
Garibaldi JM(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 10869-10398
[8]  
Ball G(2003)Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci U S A 100 10393-187
[9]  
Ellis IO(2013)Evaluating use characteristics for the oncotype dx 21-gene recurrence score and concordance with chemotherapy use in early-stage breast cancer J Oncol Pract Am Soc Clin Oncol 9 182-208
[10]  
Green AR(2013)The impact of a genomic assay (Oncotype DX) on adjuvant treatment recommendations in early breast cancer Med J Aust 199 205-22